The Sunlight Experiment

Compound Monograph

Tectorigenin

Tectorigenin is an O-methylated isoflavone of Iris tectorum and Belamcanda chinensis (She-gan) rhizome — the aglycone of tectoridin — studied preclinically for NF-κB anti-inflammatory action and a distinctive metabolic (PPARα / NAFLD, antidiabetic) signal, with modest but characterised estrogen-receptor activity. No human trials of the isolate.

Work in progress

Where Does It Come From? (2)

Tectorigenin is a naturally occurring isoflavone, found in Belamcanda chinensis / Iris domestica rhizome and Iris tectorum rhizome. It is well tolerated orally (low toxicity).

Belamcanda chinensis / Iris domestica rhizomeIris tectorum rhizome

Pharmacology & Research

Tectorigenin is an O-methylated isoflavone of She-gan rhizome — a sibling of irigenin and, like it, the aglycone of a glycoside (here tectoridin, tectorigenin 7-O-glucoside). Its preclinical profile is a reproducible NF-κB/MAPK anti-inflammatory story plus a more distinctive metabolic (PPARα/NAFLD) signal that sets it apart from irigenin. Two disciplines apply: it is documented in East-Asian She-gan species (Iris tectorum, Belamcanda chinensis), not confirmed in blue flag (I. versicolor); and it has some characterised estrogen-receptor activity — more than irigenin — but this is modest and should not be equated with soy genistein. There are no human trials of the isolate.

What the evidence supports
  • A consistent anti-inflammatory profile plus a real metabolic hook: NF-κB/MAPK suppression across tissues, and PPARα-linked improvement of NAFLD and diabetic-nephropathy endpoints in rodents 4,2,3Reference 42019Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/MAPK and TLR4/NF-κB pathways and autophagyView study →Reference 22022AnimalTectorigenin ameliorated high-fat-diet-induced non-alcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in miceView study →Reference 32020Tectorigenin attenuates diabetic nephropathy by improving vascular-endothelium dysfunction through activating the AdipoR1/2 pathwayView study →.
  • The honest headline: no human trials; the estrogen-receptor activity is real but modest (not soy-genistein-level); and human exposure is incidental via She-gan material, not a standardised isolate 10Reference 102007Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cellsView study →.
Evidence by indicationStrength of support
Anti-InflammatoryShaky
32%
Metabolic (PPAR / NAFLD)Shaky
26%
Antioxidant / HepatoprotectiveShaky
22%
Anticancer (phytoestrogen Context)Unsupported
16%
1. Anti-inflammatory

Tectorigenin blocks NF-κB activation and MAPK (ERK/JNK/p38) phosphorylation, lowering iNOS/COX-2, TNF-α, IL-6 and IL-1β across models: fulminant hepatic failure (TLR4/NF-κB and TLR4/MAPK, with autophagy) 4Reference 42019Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/MAPK and TLR4/NF-κB pathways and autophagyView study →, murine inflammatory bowel disease and LPS macrophages 5Reference 52024AnimalTectorigenin inhibits inflammatory responses in murine inflammatory bowel disease and LPS-stimulated macrophages via inactivating MAPK signallingView study →, BV-2 microglial neuroinflammation 6Reference 62018The anti-neuroinflammatory activity of tectorigenin via downregulated NF-κB and ERK/JNK pathways in BV-2 microgliaView study → and TNF-α-stimulated tendon-derived stem cells 7Reference 72020AnimalTectorigenin alleviates inflammation, apoptosis and ossification in rat tendon-derived stem cells via modulating NF-κB and MAPK pathwaysView study →; the I. tectorum rhizome extract shows the same NF-κB inhibition 13Reference 132026Iris tectorum rhizome alleviates LPS-triggered inflammatory responses through inhibiting NF-κB signalling in macrophagesView study →.

Gap: entirely preclinical, with unestablished human-achievable concentrations, and the rhizome-extract study is not isolate-specific 4,13Reference 42019Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/MAPK and TLR4/NF-κB pathways and autophagyView study →Reference 132026Iris tectorum rhizome alleviates LPS-triggered inflammatory responses through inhibiting NF-κB signalling in macrophagesView study →.

2. Metabolic (PPAR / NAFLD)

The compound’s more distinctive signal. In high-fat-diet NAFLD, tectorigenin suppressed lipogenesis (↓ SREBP-1c, ↓ FAS) and promoted fatty-acid oxidation (↑ PPARα, ↑ CPT-1) alongside anti-inflammation and gut-microbiota modulation 2Reference 22022AnimalTectorigenin ameliorated high-fat-diet-induced non-alcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in miceView study →; in diabetic nephropathy it improved vascular endothelial function via the adiponectin AdipoR1/2 pathway 3Reference 32020Tectorigenin attenuates diabetic nephropathy by improving vascular-endothelium dysfunction through activating the AdipoR1/2 pathwayView study →.

Gap: only two rodent models with no human data, and the PPARα engagement is inferred from expression changes rather than direct receptor binding 2,3Reference 22022AnimalTectorigenin ameliorated high-fat-diet-induced non-alcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in miceView study →Reference 32020Tectorigenin attenuates diabetic nephropathy by improving vascular-endothelium dysfunction through activating the AdipoR1/2 pathwayView study →.

3. Antioxidant / hepatoprotective

Tectorigenin activates the Keap1/Nrf2/HO-1 axis to blunt oxidative stress in Th2-mediated allergic asthma 8Reference 82024AnimalTectorigenin inhibits oxidative stress by activating the Keap1/Nrf2/HO-1 pathway in Th2-mediated allergic asthmatic miceView study → and, with FXR modulation, against ANIT-induced cholestatic liver injury 9Reference 92023Molecular mechanisms of the hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: role of FXR and Nrf2View study →.

Gap: preclinical, and largely a shared isoflavone-class cytoprotective effect rather than tectorigenin-unique 8,9Reference 82024AnimalTectorigenin inhibits oxidative stress by activating the Keap1/Nrf2/HO-1 pathway in Th2-mediated allergic asthmatic miceView study →Reference 92023Molecular mechanisms of the hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: role of FXR and Nrf2View study →.

4. Anticancer (phytoestrogen context)

Phytoestrogens from Belamcanda chinensis (a tectorigenin/tectoridin source) modulated steroid-receptor and cofactor expression in LNCaP prostate cancer cells 10Reference 102007Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cellsView study →, and tectorigenin induced estrogen-receptor-dependent vasorelaxation in porcine coronary arteries 11Reference 112025Tectorigenin induces vasorelaxation in porcine coronary arteries through activation of Kv channels and estrogen-receptor modulationView study →; a 2026 review catalogues broader antiproliferative signals 1Reference 12026ReviewFrom nature to pharmacy: a review of tectoridin for modern therapeuticsView study →.

Gap: thin — largely a fraction (not pure isolate) in one cell line, with no in-vivo tumour efficacy or clinical signal, and the ER activity is modest 10,11Reference 102007Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cellsView study →Reference 112025Tectorigenin induces vasorelaxation in porcine coronary arteries through activation of Kv channels and estrogen-receptor modulationView study →.

Mechanisms

Target / pathwayEffectRelevant to
NF-κB; MAPK (p38/ERK/JNK); TLR4inhibited/suppressedanti-inflammatory, hepatoprotection
SREBP-1c, FAS; PPARα, CPT-1↓ lipogenesis; ↑ fatty-acid oxidationmetabolic / NAFLD
AdipoR1/2 (adiponectin)activateddiabetic nephropathy / endothelial function
Keap1 / Nrf2 → HO-1; FXRactivated; modulatedantioxidant, cholestatic-liver protection
Estrogen receptor; steroid receptors (LNCaP)modulated (partial agonist/modulator)phytoestrogen / vascular / prostate context
UGT1A1 / UGT1A9substrate (glucuronidation)pharmacokinetics

Pharmacokinetics

Tectorigenin is an O-methylated isoflavone aglycone with poor oral bioavailability and extensive phase-II conjugation — a confirmed substrate of UGT1A1 and UGT1A9 for glucuronidation in vitro (the same study covering irigenin) 12Reference 122022In vitroUGT1A1 and UGT1A9 are responsible for the phase-II metabolism of tectorigenin and irigenin in vitroView study →. It is the active aglycone of tectoridin (tectorigenin 7-O-glucoside): the glycoside is poorly absorbed and released/hydrolysed by gut microflora to tectorigenin before absorption. The net picture is low systemic exposure of the free aglycone, heavy glucuronidation and microbiota-dependent deglycosylation when delivered as tectoridin — with no human pharmacokinetic data.

Clinical trials

There are no human clinical trials of isolated tectorigenin; all evidence is in-vitro or rodent, and human exposure occurs only incidentally via Iris tectorum/Belamcanda chinensis (She-gan) preparations.

CompletedPlannedTerminatedPreclinical
—(none, isolate)——Moderate

Last checked: July 2026.

Toxicity & Safety

Tectorigenin has a low isolate-toxicity signal — no isolated-compound toxicology, genotoxicity or repeat-dose human data exist, and preclinical studies use it as a protective/anti-inflammatory/metabolic agent without reported acute toxicity at tested doses. As an isoflavone it carries the generic hormonal caveat, and because its ER activity is better characterised than irigenin’s, that caveat is somewhat more applicable here (though still far weaker and less-studied than soy genistein). Whole-rhizome She-gan preparations have their own traditional-use safety profile that should not be conflated with the purified isolate.

Pregnancy & lactation

Avoid (isolated supplement). Dietary exposure is not applicable — tectorigenin is not a meaningful dietary constituent — and as an isolated isoflavone with demonstrable ER activity and no reproductive or developmental safety data, it is not recommended in pregnancy or lactation.

Dosage

There is no established human dose — tectorigenin is not sold or used as a standardised isolate and appears only within Iris tectorum/Belamcanda (She-gan) herbal material, as the aglycone of tectoridin, so no evidence-based dosage can be given.

References

  1. (2026). From nature to pharmacy: a review of tectoridin for modern therapeutics. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/42198377/
  2. (2022). Tectorigenin ameliorated high-fat-diet-induced non-alcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice. Food and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/35390440/
  3. (2020). Tectorigenin attenuates diabetic nephropathy by improving vascular-endothelium dysfunction through activating the AdipoR1/2 pathway. Pharmacological Research. https://pubmed.ncbi.nlm.nih.gov/32014572/
  4. (2019). Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/MAPK and TLR4/NF-κB pathways and autophagy. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/30701601/
  5. (2024). Tectorigenin inhibits inflammatory responses in murine inflammatory bowel disease and LPS-stimulated macrophages via inactivating MAPK signalling. Immunity, Inflammation and Disease. https://pubmed.ncbi.nlm.nih.gov/38722267/
  6. (2018). The anti-neuroinflammatory activity of tectorigenin via downregulated NF-κB and ERK/JNK pathways in BV-2 microglia. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/29867470/
  7. (2020). Tectorigenin alleviates inflammation, apoptosis and ossification in rat tendon-derived stem cells via modulating NF-κB and MAPK pathways. Frontiers in Cell and Developmental Biology. https://pubmed.ncbi.nlm.nih.gov/33195199/
  8. (2024). Tectorigenin inhibits oxidative stress by activating the Keap1/Nrf2/HO-1 pathway in Th2-mediated allergic asthmatic mice. Free Radical Biology and Medicine. https://pubmed.ncbi.nlm.nih.gov/38147892/
  9. (2023). Molecular mechanisms of the hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: role of FXR and Nrf2. Food and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/37348807/
  10. (2007). Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells. BJU International. https://pubmed.ncbi.nlm.nih.gov/17488304/
  11. (2025). Tectorigenin induces vasorelaxation in porcine coronary arteries through activation of Kv channels and estrogen-receptor modulation. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/41136421/
  12. (2022). UGT1A1 and UGT1A9 are responsible for the phase-II metabolism of tectorigenin and irigenin in vitro. Molecules. https://pubmed.ncbi.nlm.nih.gov/35807350/
  13. (2026). Iris tectorum rhizome alleviates LPS-triggered inflammatory responses through inhibiting NF-κB signalling in macrophages. Biomedicines. https://pubmed.ncbi.nlm.nih.gov/42351719/